Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multisystem
involvement. It is multifactorial and involves epigenetic, genetic, ecological, and …

With novel therapies in development, there is an opportunity to consider asthma remission
as a treatment goal. In this Rostrum, we present a generalized framework for clinical and …

Systemic lupus erythematosus (SLE) is characterized by immune system dysfunction and is
clinically heterogeneous, exhibiting renal, dermatological, neuropsychiatric, and …

Extracellular tissue fluids are interesting biomatrices that have recently attracted scientists'
interest. Many significant biomarkers for localized external organ diseases have been …

The long noncoding RNAs (lncRNAs) are RNA transcripts more than 200 nucleotides in
length, which do not encode proteins. The lncRNAs are emerging as an important regulator …

Systemic lupus erythematosus (SLE) is a very complex disease where multiple
immunological pathways can concur in inducing tissue damage. Cytokines are key …

Mitophagy is an evolutionarily conserved process to selectively remove damaged or
unnecessary mitochondria via the autophagic machinery. In this review, we focus on recent …

Autoantibodies are well known as potentially highly harmful antibodies which attack the host
via binding to self-antigens, thus causing severe associated diseases and symptoms (eg …

During the last decades, there has been an increased interest in the discovery and
validation of biomarkers that reliably reflect specific aspects of lupus. Although many …

Background and objective Lupus nephritis (LN) is a major complication in patients with
systemic lupus erythematosus (SLE). Tubulointerstitial injury is an inflammatory process that …